e-Drug3D

775

CABERGOLINE


INN
CABERGOLINE

cas 81409-90-7
CLASS

NERVOUS SYSTEM
PROLACTIN SECRETION INHIBITOR
ANTIPARKINSON AGENTS
DOPAMINE AGONISTS

ROUTE (list)

ORAL

ATC code

G02CB03
N04BC06

PK parameters

Tmax 2.5 HOUR
Cl 192 LITER / HOUR
PPB 41 PERCENT
t1/2 66 HOUR

Solubility

INSOLUBLE IN WATER


Target

TARGET D(2) DOPAMINE RECEPTOR

DrugCentral

D(2) dopamine receptor UNIPROT P14416 DRD2

Download SDF file N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]- 6-(2-propenyl)-8g-ergoline-8-carboxamide

Formula:
C26H37N5O2

Calculated chemical properties:

MW 451.61
NB_atoms 33
XLogP 3.19
PSA 66.177
NB_HD 2
NB_HA 7
fsp3 0.54
Lipinski(0=no;1=yes) 1

FDA
NDA 020664 (pdf not found) INN (CABERGOLINE) DOSTINEX (PFIZER) APPROVAL= AP YEAR= 1996 NEWMOLECULARENTITY DISCONTINUED
NDA 076310 (pdf not found) INN (CABERGOLINE) CABERGOLINE (STRIDES PHARMA) APPROVAL= AP YEAR= 2005
NDA 077750 (pdf not found) INN (CABERGOLINE) CABERGOLINE (IVAX SUB TEVA PHARMS) APPROVAL= AP YEAR= 2007
NDA 077843 (pdf not found) INN (CABERGOLINE) CABERGOLINE (IMPAX LABS INC) APPROVAL= AP YEAR= 2007 DISCONTINUED
NDA 078035 (pdf not found) INN (CABERGOLINE) CABERGOLINE (ACTAVIS LABS FL INC) APPROVAL= AP YEAR= 2008 DISCONTINUED
NDA 201503 (pdf not found) INN (CABERGOLINE) CABERGOLINE (APOTEX CORP) APPROVAL= AP YEAR= 2013 DISCONTINUED
NDA 202947 (pdf not found) INN (CABERGOLINE) CABERGOLINE (PHARMOBEDIENT) APPROVAL= AP YEAR= 2013 DISCONTINUED
NDA 204735 (pdf not found) INN (CABERGOLINE) CABERGOLINE (INGENUS PHARMS LLC) APPROVAL= AP YEAR= 2018
NDA 218109 (pdf not found) INN (CABERGOLINE) CABERGOLINE (SOMERSET THERAPS LLC) APPROVAL= AP YEAR= 2024
NDA 218618 (pdf not found) INN (CABERGOLINE) CABERGOLINE (SKG PHARMA) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL